EVOLVE Myelofibrosis
January 2026
By understanding new and emerging myelofibrosis treatment choices, patients and care partners can feel well informed and confident when asking their healthcare team about the latest treatment options and/or clinical trials. Evolve Myelofibrosis provides patients and care partners with actionable steps and resources to encourage discussions with their healthcare team about their care.
Program topics include:
Personalize Your Experience!
Create an account to save items and receive information curated just for you.
Understanding New and Developing Myelofibrosis Treatment
Bone Marrow Transplant for Myelofibrosis | What You Should Know
January 13, 2026
Looking Forward | The Evolving Myelofibrosis Treatment Landscape
January 13, 2026
ASH 2025 Update | Myelofibrosis Treatment and Research Findings
January 13, 2026
Promising Advances in Myelofibrosis Research | Optimism for Patients
December 5, 2024
Expert Outlook | New Myelofibrosis Therapies Showing Promise
October 17, 2024
Updates in Myelofibrosis Research From an Expert
October 17, 2024
What Are the Currently Approved Myelofibrosis Therapies?
April 1, 2024
Is Stem Cell Transplant the Only Curative Option for Myelofibrosis?
November 28, 2023
Myelofibrosis Therapies in Clinical Trials | BET Inhibitors
November 28, 2023
Tools for Myelofibrosis Patient Self-Advocacy
Interested in a Myelofibrosis Clinical Trial? Start Here.
January 13, 2026
Why Myelofibrosis Patients Should Be Engaged in Their Care Decisions
December 5, 2024
EVOLVE Myelofibrosis Resource Guide
December 4, 2024
How Can You Learn More About Myelofibrosis Clinical Trials?
October 17, 2024
Choosing a Myelofibrosis Treatment Plan | Key Questions to Ask
November 28, 2023
EVOLVE Myelofibrosis is brought to you by the Patient Empowerment Network. Funding is provided by a sponsorship from Merck, MorphoSys, and through generous donations from people like you.